.grx-pd { /* no font-size: inherits the theme's body text size so this block matches surrounding UI on both Shopify and Zoey */ max-width: 760px; font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; color: #1a1a1a; line-height: 1.5; } .grx-pd__intro { font-size: 1em; margin: 0 0 1.75rem; } /* em = relative to inherited body size */ .grx-pd__intro strong { color: #0f0f0f; } /* auto-fit grid: cards reflow from 1 col on mobile to 2 on wider screens without media queries */ .grx-pd__grid { display: grid; grid-template-columns: repeat(auto-fit, minmax(260px, 1fr)); gap: 14px; margin: 0 0 2rem; } .grx-pd__card { background: #f7f8fa; color: #3d3d3d; border-radius: 0; padding: 16px 18px; font-size: 1em; /* matches theme body text exactly */ transition: box-shadow .15s ease, transform .15s ease; } .grx-pd__card:hover { /* subtle lift signals these are discrete data points, not a plain list */ box-shadow: 0 4px 14px rgba(0,0,0,.06); } .grx-pd__card-title { /* larger + heavier than body so the mechanism reads first, body copy second */ display: block; font-size: 1em; font-weight: 700; color: #0f0f0f; margin: 0 0 .5rem; line-height: 1.5; } /* disclaimer intentionally low-contrast + small: legally present, visually de-emphasized */ .grx-pd__legal { border-top: 1px solid #e6e8ec; padding-top: 1.5rem; font-size: 1em; color: #6b7280; line-height: 1.55; } .grx-pd__legal p { margin: 0 0 .6rem; font-size: 1em;} .grx-pd__legal p:last-child { margin-bottom: 0; } Tesamorelin is a synthetic analog of endogenous growth hormone-releasing hormone (GHRH) featuring a trans-3-hexenoic acid modification that enhances its stability and bioavailability. It acts by binding to the GHRH receptor on the anterior pituitary gland, thereby stimulating the physiological release of growth hormone in a pulsatile manner consistent with endogenous regulatory mechanisms. GHRH Receptor ActivationTesamorelin activates the GHRH receptor to promote pulsatile secretion of growth hormone from the anterior pituitary. Hypothalamic-Pituitary FeedbackTesamorelin supports maintenance of natural feedback regulation within the hypothalamic-pituitary axis. Body Composition ModulationTesamorelin has been evaluated in peer-reviewed literature for its potential role in modulating body composition parameters, including reductions in visceral adipose tissue in preclinical models. Lipid Metabolism EffectsTesamorelin is associated with effects on lipid metabolism, including modulation of triglyceride levels and cholesterol ratios in clinical studies. Physiologic IGF-1 MaintenanceTesamorelin may support body composition changes without inducing supraphysiologic elevations of insulin-like growth factor-1 (IGF-1) when administered at appropriate doses. This product is intended for use by licensed healthcare providers in clinical settings. It is not intended for consumer sale. Buyer/doctor has determined and documented that the use of this product is appropriate for the patient based on the assessment of the patient's needs. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For professional use only. Lead time: 1-2 Weeks
Related
Related
Related